ResMed Inc. (RMD)
NYSE: RMD · IEX Real-Time Price · USD
203.15
-0.73 (-0.36%)
At close: Jul 19, 2024, 4:00 PM
203.68
+0.53 (0.26%)
Pre-market: Jul 22, 2024, 7:42 AM EDT
ResMed Employees
ResMed had 10,140 employees as of June 30, 2023. The number of employees increased by 1,980 or 24.26% compared to the previous year.
Employees
10,140
Change (1Y)
1,980
Growth (1Y)
24.26%
Revenue / Employee
$452,087
Profits / Employee
$94,515
Market Cap
29.84B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | 7,770 | 530 | 7.32% |
Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
Jun 30, 2018 | 5,940 | -140 | -2.30% |
Jun 30, 2017 | 6,080 | 830 | 15.81% |
Jun 30, 2016 | 5,250 | 910 | 20.97% |
Jun 30, 2015 | 4,340 | 240 | 5.85% |
Jun 30, 2014 | 4,100 | 200 | 5.13% |
Jun 30, 2013 | 3,900 | 200 | 5.41% |
Jun 30, 2012 | 3,700 | 250 | 7.25% |
Jun 30, 2011 | 3,450 | 250 | 7.81% |
Jun 30, 2010 | 3,200 | 300 | 10.34% |
Jun 30, 2009 | 2,900 | 200 | 7.41% |
Jun 30, 2008 | 2,700 | 0 | - |
Jun 30, 2007 | 2,700 | 200 | 8.00% |
Jun 30, 2006 | 2,500 | 573 | 29.74% |
Jun 30, 2005 | 1,927 | 407 | 26.78% |
Jun 30, 2004 | 1,520 | 56 | 3.83% |
Jun 30, 2003 | 1,464 | 214 | 17.12% |
Jun 30, 2002 | 1,250 | 297 | 31.16% |
Jun 30, 2001 | 953 | 348 | 57.52% |
Jun 30, 2000 | 605 | 104 | 20.76% |
Jun 30, 1999 | 501 | 111 | 28.46% |
Jun 30, 1998 | 390 | 106 | 37.32% |
Jun 30, 1997 | 284 | 55 | 24.02% |
Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Centene | 67,000 |
GE HealthCare Technologies | 51,000 |
ICON PLC | 41,100 |
Agilent Technologies | 18,100 |
Mettler-Toledo International | 17,300 |
IDEXX Laboratories | 11,000 |
Biogen | 7,570 |
Veeva Systems | 7,172 |
RMD News
- 14 days ago - 5 Stocks With Solid Growth History and a Promising Outlook - Kiplinger
- 18 days ago - ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024 - GlobeNewsWire
- 24 days ago - ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. - Barrons
- 27 days ago - ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday - Benzinga
- 27 days ago - Why a Pair of Eli Lilly Clinical Trials Sent ResMed Stock Tumbling - Investopedia
- 27 days ago - Medical-device makers ResMed and Inspire slump after Lilly's Zepbound trial shows benefits for sleep apnea - Market Watch
- 4 weeks ago - ResMed Stock Is Sinking. Blame Lilly's Zepbound Trials for Sleep Apnea. - Barrons
- 5 weeks ago - PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia - GlobeNewsWire